Cognitive Testing for People Living with HIV
Learn More about Our Partnership with a Lead Researcher at John’s Hopkins School of Medicine December 1st is World AIDS Day. To bring light to …
Neurology
Clinical ink Mobile Gait Assessment
Measure Visuomotor Coordination, Balance, and Motor Performance The Clinical ink Mobile Gait and Balance Assessment measures visuomotor coordination, balance, and motor performance. It utilizes multiple …
Clinical ink Mobile Postural Tremor Assessment
Measure Arm Stability and Motor Performance The Clinical ink Mobile Postural Tremor Assessment measures arm stability and motor performance by measuring moment-to-moment changes in upper …
Clinical ink Mobile Finger Tapping Test
Measure Visuomotor Coordination and Motor Performance The Clinical ink Mobile Finger Tapping Test measures a patient’s ability to rapidly generate and coordinate rhythmic motor movements. …
Clinical ink Mobile Phonation Assessment
Measure Emotional Affect, Voice, and Respiratory Function The Clinical ink Mobile Phonation Assessment measures emotional affect, voice and respiratory function. Data from the phonation assessment …
Use of Advanced eCOA Technology Streamlines Complex Neuropsychological Assessment: RBANS®
An Interview With Cogstate Neuropsychologist Robert McCue Central Nervous System (CNS) clinical outcome assessments — particularly Performance Outcome (PerfO) based measures — are among the …
Clinical ink Adds 16th Concurrent Alzheimer’s Study Supporting 9,000+ Patients Across 25 Countries
HORSHAM, Pa.; April 6, 2021 – Clinical ink, a global clinical trial technology company, today announced it has added its 16th concurrent Phase II/III Alzheimer’s …
Cogstate and Clinical Ink Deliver Enhanced Tablet-Based eCOA for CNS Clinical Trials
NEW HAVEN, CT & PHILADELPHIA, PA – October 25, 2016 – Cognitive science company, Cogstate Ltd (ASX.CGS) and Clinical Ink, the leading provider of eSource …
Cogstate and Clinical Ink Deliver Enhanced Tablet-Based eCOA for CNS Clinical Trials Read More…
